State Street Corp Aytu Biopharma, Inc Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.2 - $3.86 $19,536 - $377,060	-97,684 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.73 - $7.56 $376,635 - $601,980	-79,627 Reduced 44.91%	97,684 $489,000
Q1 2021 May 17, 2021	BUY	$6.23 - $9.88 $797,689 - $1.27 Million	128,040 Added 259.87%	177,311 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$5.98 - $13.5 $294,640 - $665,158	49,271 New	49,271 $295,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.